Stock Price
6.93
Daily Change
-0.42 -5.71%
Monthly
42.59%
Yearly
82.37%
Q1 Forecast
6.76

Silence Therapeutics reported $146.79M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
AstraZeneca USD 114.07B 382M Dec/2025
Autolus Therapeutics Ltd USD 661.95M 59.03M Sep/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Novartis USD 107.29B 2.89B Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Silence Therapeutics USD 146.79M 18.44M Sep/2025